Try our Advanced Search for more refined results
Prolacta Bioscience Inc.
-
Order | Filed: June 01, 2022 | Entered: June 01, 2022 Ni-Q, LLC v. Prolacta Bioscience, Inc.
Patent | Oregon
Opinion and Order
Opinion and Order - The Court DENIES Ni-Q's Motion for Attorney's Fees, ECF 260 . The Court approves Ni-Q's cost bill, ECF 258 . Signed on 6/1/2022 by Judge Michael H. Simon. (mja)
-
Response | Filed: January 26, 2022 | Entered: January 26, 2022 Ni-Q, LLC v. Prolacta Bioscience, Inc.
Patent | Oregon
Reply to Motion
Reply to Opposition to Motion for Attorney Fees 260 , Motion to Strike Motion for Attorney Fees 260 263 . Filed by Ni-Q, LLC. (Legaard, Brenna)
-
Response | Filed: December 29, 2021 | Entered: December 29, 2021 Ni-Q, LLC v. Prolacta Bioscience, Inc.
Patent | Oregon
Response in Opposition to Motion
Response in Opposition to Motion for Attorney Fees 260 . Filed by Prolacta Bioscience, Inc.. (Armon, Orion)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login